
Privacy notice | Accessibility statement | Terms and conditions | Login | Contact |
UK data driving real-world evidence
Bibliography
Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,600 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 4 January 2021) and papers are listed below and in the PDF below.
If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.
Download:
(PDF, 3MB, 218 pages)This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website.
“The pattern of risk of myocardial infarction in patients taking asthma medication: a study with the General Practice Research Database”, J Hypertens, vol. 27, pp. 1485-92, 2009.
, “Pattern of risks of rheumatoid arthritis among patients using statins: A cohort study with the clinical practice research datalink”, PLoS One, vol. 13, p. e0193297, 2018.
, “Pattern of risks of systemic lupus erythematosus among statin users: a population-based cohort study”, Ann Rheum Dis, vol. 76, pp. 1723-1730, 2017.
, “Patterns of risk of cancer in patients with metal-on-metal hip replacements versus other bearing surface types: a record linkage study between a prospective joint registry and general practice electronic health records in England”, PLoS One, vol. 8, p. e65891, 2013.
, “Predicting the 10-year risk of hip and major osteoporotic fracture in rheumatoid arthritis and in the general population: an independent validation and update of UK FRAX without bone mineral density”, Ann Rheum Dis, vol. 75, pp. 2095-2100, 2016.
, “Prevalence of antibiotic use: a comparison across various European health care data sources”, Pharmacoepidemiol Drug Saf, vol. 25 Suppl 1, pp. 11-20, 2016.
, “Quality of INR control and outcomes following venous thromboembolism”, Clin Appl Thromb Hemost, vol. 18, pp. 370-8, 2012.
, “Reanalysis of two studies with contrasting results on the association between statin use and fracture risk: the General Practice Research Database”, Int J Epidemiol, vol. 35, pp. 1301-8, 2006.
, “Remission of Type 2 Diabetes Mellitus in Patients After Different Types of Bariatric Surgery: A Population-Based Cohort Study in the United Kingdom”, JAMA Surg, vol. 150, pp. 1126-33, 2015.
, “Risk of a first-ever acute myocardial infarction and all-cause mortality with sulphonylurea treatment: A population-based cohort study”, Diabetes Obes Metab, vol. 20, pp. 1056-1060, 2018.
, “Risk of bladder cancer in patients with diabetes: a retrospective cohort study”, BMJ Open, vol. 5, p. e007470, 2015.
, “Risk of cataract and glaucoma in patients with multiple sclerosis”, Mult Scler, vol. 18, pp. 628-38, 2012.
, “The risk of colorectal cancer in patients with type 2 diabetes: associations with treatment stage and obesity”, Diabetes Care, vol. 38, pp. 495-502, 2015.
, “Risk of community-acquired pneumonia in chronic obstructive pulmonary disease stratified by smoking status: a population-based cohort study in the United Kingdom”, Int J Chron Obstruct Pulmon Dis, vol. 12, pp. 2425-2432, 2017.
, “Risk of fracture after bariatric surgery in the United Kingdom: population based, retrospective cohort study”, Bmj, vol. 345, p. e5085, 2012.
, “Risk of fracture in patients with Charcot-Marie-Tooth disease”, Muscle Nerve, vol. 50, pp. 919-24, 2014.
, “Risk of fracture in patients with Guillain-Barre syndrome”, Osteoporos Int, vol. 25, pp. 1845-51, 2014.
, “The risk of fracture in patients with multiple sclerosis: the UK general practice research database”, J Bone Miner Res, vol. 26, pp. 2271-9, 2011.
, “Risk of fracture in patients with muscular dystrophies”, Osteoporos Int, vol. 25, pp. 509-18, 2014.
, “Risk of fracture in patients with Parkinson's disease”, Osteoporos Int, vol. 24, pp. 2283-90, 2013.
, “Risk of fracture with thiazolidinediones: an individual patient data meta-analysis”, Front Endocrinol (Lausanne), vol. 4, p. 11, 2013.
, “Risk of hypoglycaemia in users of sulphonylureas compared with metformin in relation to renal function and sulphonylurea metabolite group: population based cohort study”, Bmj, vol. 354, p. i3625, 2016.
, “Risk of infections in patients with gout: a population-based cohort study”, Sci Rep, vol. 7, p. 1429, 2017.
, “Risk of lactic acidosis or elevated lactate concentrations in metformin users with renal impairment: a population-based cohort study”, Diabetes Care, vol. 37, pp. 2218-24, 2014.
, “The risk of major and any (non-hip) fragility fracture after hip fracture in the United Kingdom: 2000-2010”, Osteoporos Int, vol. 25, pp. 2555-63, 2014.
, “Risk of major bleeding and stroke associated with the use of vitamin K antagonists, nonvitamin K antagonist oral anticoagulants and aspirin in patients with atrial fibrillation: a cohort study”, Br J Clin Pharmacol, vol. 83, pp. 1844-1859, 2017.
, “Risk of myocardial infarction in patients with atrial fibrillation using vitamin K antagonists, aspirin or direct acting oral anticoagulants”, Br J Clin Pharmacol, vol. 83, pp. 1835-1843, 2017.
, “The risk of new fragility fractures in patients with chronic kidney disease and hip fracture-a population-based cohort study in the UK”, Osteoporos Int, 2020.
, “The risk of venous thromboembolism in patients with multiple sclerosis: the Clinical Practice Research Datalink”, J Thromb Haemost, vol. 12, pp. 444-51, 2014.
, “Risk of vertebral and non-vertebral fractures in patients with sarcoidosis: a population-based cohort”, Osteoporos Int, vol. 27, pp. 1603-1610, 2016.
, “Safety and efficacy of new oral anticoagulants and low-molecular-weight heparins compared with aspirin in patients undergoing total knee and hip replacements”, Pharmacoepidemiol Drug Saf, vol. 25, pp. 1245-1252, 2016.
, “Secular trends in fracture incidence in the UK between 1990 and 2012”, Osteoporos Int, vol. 27, pp. 3197-3206, 2016.
, “Severity of Diabetes Mellitus and Total Hip or Knee Replacement: A Population-Based Case-Control Study”, Medicine (Baltimore), vol. 95, p. e3739, 2016.
, “Severity of obstructive airway disease and risk of osteoporotic fracture”, Eur Respir J, vol. 25, pp. 879-84, 2005.
, “A simple score for estimating the long-term risk of fracture in patients with multiple sclerosis”, Neurology, vol. 79, pp. 922-8, 2012.
, “Smoke-free legislation and the incidence of paediatric respiratory infections and wheezing/asthma: interrupted time series analyses in the four UK nations”, Sci Rep, vol. 5, p. 15246, 2015.
, “Stability of Blood Eosinophils in Patients with Chronic Obstructive Pulmonary Disease and in Control Subjects, and the Impact of Sex, Age, Smoking, and Baseline Counts”, Am J Respir Crit Care Med, vol. 195, pp. 1402-1404, 2017.
, “Trends in moderate and severe exacerbations among COPD patients in the UK from 2005 to 2013”, Respir Med, vol. 144, pp. 1-6, 2018.
, “Trends in oral anti-osteoporosis drug prescription in the United Kingdom between 1990 and 2012: Variation by age, sex, geographic location and ethnicity”, Bone, vol. 94, pp. 50-55, 2017.
, “Use of beta-blockers and the risk of hip/femur fracture in the United Kingdom and The Netherlands”, Calcif Tissue Int, vol. 80, pp. 69-75, 2007.
, “Use of dipeptidyl peptidase-4 inhibitors for type 2 diabetes mellitus and risk of fracture”, Bone, vol. 68, pp. 124-30, 2014.
, “Use of Dipeptidyl-Peptidase-4 Inhibitors and the Risk of Pneumonia: A Population-Based Cohort Study”, PLoS One, vol. 10, p. e0139367, 2015.
, “Use of incretin agents and risk of acute and chronic pancreatitis: A population-based cohort study”, Diabetes Obes Metab, vol. 19, pp. 401-411, 2017.
, “Use of incretin agents and risk of pancreatic cancer: a population-based cohort study”, Diabetes Obes Metab, vol. 18, pp. 258-65, 2016.
, “Use of parenteral glucocorticoids and the risk of new onset type 2 diabetes mellitus: A case-control study”, Diabetes Res Clin Pract, vol. 139, pp. 100-106, 2018.
, “Use of proton pump inhibitors and risk of iron deficiency: a population-based case-control study”, J Intern Med, 2018.
, “Use of proton pump inhibitors and risk of iron deficiency: a population-based case-control study”, J Intern Med, vol. 285, pp. 205-214, 2019.
, “Use of Sodium-Glucose Co-Transporter-2-Inhibitors (SGLT2-Is) and Risk of Lower Limb Amputation”, Curr Drug Saf, 2020.
, “Use of statins and risk of fractures”, Jama, vol. 285, pp. 1850-5, 2001.
, “Use of thiazolidinediones and the risk of elective hip or knee replacement: a population based case-control study”, Br J Clin Pharmacol, vol. 81, pp. 370-8, 2016.
,